ArticleThe New England journal of medicine2019

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.

Timothy P Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.